IMS Health (IMS) Approves $250M Common Stock Buyback Plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/21/2026
- Wall St futures gain as chip stocks extend recovery; earnings in focus
- Oil prices rise nearly 2% on fresh attacks by US and Iran
- Chip stocks extend global rebound following last week's rout
- Adobe, Salesforce and Intuit fall as Morgan Stanley begins cautious coverage
- Danaher shares tumble despite earnings beat
- U.S. to impose 50% tariff on most Canadian goods, including USMCA
- NVIDIA reports 9.3% passive stake in Nebius
- Intersnack to acquire Utz Brands at $14.25 per share in go-private deal
- Wall Street indexes fall, with Iran and earnings season in focus
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
Barclays Downgrades IMS Health Holdings (IMS) to Equalweight
December 17, 2015 7:31 AM ESTBarclays downgraded IMS Health Holdings (NYSE: IMS) from Overweight to Equalweight with a price target of $28.00 (from $33.00).
For an analyst ratings summary and ratings history on IMS Health Holdings click here. For more ratings news on IMS Health Holdings click here.
Shares of IMS Health Holdings closed at $25.71 yesterday.
... More